3. Applications of Artificial Intelligence in Drug Design: Opportunities and Challenges¶
3.1. 1 Introduction: What Challenges Does Drug Design Face?¶
cost has increased dramatically
Around 80% of failures in clinical trials occur
insufficient efficacy or safety in patients.
Many datasets have been gathered on the properties, reactions, and interactions of chemical compounds; however, this data is disproportionately focused on a small range of well-studied endpoints.